Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

16.7%

1 terminated/withdrawn out of 6 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

50%

2 of 4 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

N/A

2(40.0%)

Phase 2

1(20.0%)

Early Phase 1

1(20.0%)

Phase 3

1(20.0%)

5Total

N/A(2)

Phase 2(1)

Early Phase 1(1)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT06992141Early Phase 1Completed

A Strep Throat Controlled Human Infection Trial in Healthy Adults

Role: collaborator

NCT01719211Unknown

Genetic Basis of Mitral Valve Prolapse

Role: collaborator

NCT00534703Phase 2Terminated

Investigation of the Safety and Feasibility of AAV1/SERCA2a Gene Transfer in Patients With Chronic Heart Failure

Role: collaborator

NCT01752842Not ApplicableCompleted

Lipid Biomarkers for Diabetic Heart Disease

Role: collaborator

NCT02230098Phase 3Completed

Effects of Remote Ischemic Conditioning on Myocardial Perfusion in Humans

Role: collaborator

NCT00799565Not ApplicableCompleted

Mitral Valve Prolapse (MVP) - France Study

Role: collaborator

All 6 trials loaded